CN1528413A - Medicine for treating bum, empyrosis and bedsore - Google Patents
Medicine for treating bum, empyrosis and bedsore Download PDFInfo
- Publication number
- CN1528413A CN1528413A CNA2003101058270A CN200310105827A CN1528413A CN 1528413 A CN1528413 A CN 1528413A CN A2003101058270 A CNA2003101058270 A CN A2003101058270A CN 200310105827 A CN200310105827 A CN 200310105827A CN 1528413 A CN1528413 A CN 1528413A
- Authority
- CN
- China
- Prior art keywords
- medicine
- burn
- portions
- vegetable oil
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 229940079593 drug Drugs 0.000 title claims description 12
- 208000004210 Pressure Ulcer Diseases 0.000 title abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 206010053615 Thermal burn Diseases 0.000 claims abstract description 11
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 9
- 239000008158 vegetable oil Substances 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 11
- 208000025865 Ulcer Diseases 0.000 claims description 9
- 239000007766 cera flava Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 231100000397 ulcer Toxicity 0.000 claims description 9
- 244000293323 Cosmos caudatus Species 0.000 claims description 4
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 4
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- 208000013935 Electric injury Diseases 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000157653 Psora Species 0.000 abstract 1
- 241000219061 Rheum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 235000013871 bee wax Nutrition 0.000 abstract 1
- 239000012166 beeswax Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 22
- 208000027418 Wounds and injury Diseases 0.000 description 22
- 238000011282 treatment Methods 0.000 description 19
- 239000002674 ointment Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 230000035876 healing Effects 0.000 description 8
- 230000029663 wound healing Effects 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 210000000589 cicatrix Anatomy 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 230000036559 skin health Effects 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 238000001266 bandaging Methods 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229960003600 silver sulfadiazine Drugs 0.000 description 2
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 208000003656 Electric Burns Diseases 0.000 description 1
- QYZBCWXZSYTIOY-UHFFFAOYSA-N Mercuric oxide Chemical compound [O-2].[Hg+2] QYZBCWXZSYTIOY-UHFFFAOYSA-N 0.000 description 1
- 208000004221 Multiple Trauma Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000019878 epithelium migration Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000000835 hypertrophic cicatrix Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- APTZNLHMIGJTEW-UHFFFAOYSA-N pyraflufen-ethyl Chemical compound C1=C(Cl)C(OCC(=O)OCC)=CC(C=2C(=C(OC(F)F)N(C)N=2)Cl)=C1F APTZNLHMIGJTEW-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a medicine for high-effectively and quickly curing burn, scald, electric injury, bed sore and various sore and psora infections with obvious therapeutic effect. The main composition of said medicine comprises (by weight portion) 10-20 portions of rhubarb, 0.1-2 portions of pearl, 2-10 portions of calcined alum, 10-35 portions of calcined gypsum, 1-3 portions of borneol, 3-5 portions of beeswax and 30-50 portions of vegetable oil. Besides, in the above-mentioned composition the bovine bezoar, musk and Span also can be added. Said invention also provides its preparation method and concrete steps.
Description
Technical field
This medicine belongs to the treatment skin burn and scald and injures para-infectious medicines such as decubital ulcer.
Background technology
Burn is a kind of commonly encountered diseases.Patient is painful big, especially at the burn initial stage.Burn is in agglutination, and wound surface is easily infected, and healing time is longer.Very easily produce hypertrophic cicatrix after the healing, cause deformity and dysfunction.And medical expense is higher.For burn wound being healed as early as possible and preventing that the later stage scar hyperplasia from being the difficult point and the emphasis of present burn treating, also be simultaneously the important indicator of estimating burn treating level height.The wound surface medicine for external use plays an important role in the burn treatment.At ordinary times or wartime, middle small size II degree is scalded and is occupied the majority, and all accounts for whole aing burn case more than 80%.This part patient's main Therapeutic Method is a wound surface local application, so the quality of medicine plays crucial effect.Husky cloth of many at present employing vaseline and treatments such as 1% silver sulfadiazine solution or upright credible gel have certain effect.Though the wound surface external used medicine is of a great variety clinically at present, promoting healing and preventing that effect is neither enough desirable aspect the cicatrix still do not have a kind of more gratifying medicine.Also there is the not high shortcoming of curative effect of medication in the treatment that thunderbolt wound, decubital ulcer and various skin ulcer scabies are infected in addition.Still do not have a kind of efficiently, fast at present, can control the medicine that burn and scald can be treated skin ulcer scabies class again.Exist treatment time long for burn and scald, easily stay shortcomings such as cicatrix.
Summary of the invention
The objective of the invention is to avoid the above-mentioned deficiency of existing therapy, a kind of efficient more rapid healing burn and scald, decubital ulcer and the para-infectious medicine of various skin ulcer scabies are provided; Make burn and scald after healing, not stay cicatrix.
For achieving the above object, the applicant through clinical practice for many years, excavates out a kind of new wound surface medicine for external use according to Traditional Chinese medical theory, and proof has better therapeutic effect really.
This treatment burn and scald injures the drug main of decubital ulcer will be made of (weight portion) following ingredients:
(1) Radix Et Rhizoma Rhei 10-20 part
(2) Margarita 0.1-2 part
(3) dried Alumen 2-10 part
(4) Gypsum Fibrosum Preparatum 10-35 part
(5) Borneolum Syntheticum 1-3 part
(6) Cera Flava 3-5 part
(7) vegetable oil 30-50 part
Here said vegetable oil can be Oleum sesami, Oleum Arachidis hypogaeae semen or Oleum Glycines etc.
In order further to improve effect, on the basis of above-mentioned component, also can comprise following composition (weight portion):
Calculus Bovis 0.01-0.1 part
Moschus 0.001-0.01 part
Span 40 0.5-2 part
The medicine of above-mentioned compatibility should be made ointment and use.Can adopt existing various ointment method for making for this reason.Common Chinese teacher can both be implemented according to a conventional method.But in order to reach better effect, preferably make extractum rhei earlier, vegetable oil, the Cera Flava with heating mixes again, adds other Chinese medicine fine powder at last.
Prepare the method for said medicine, preferably include following steps:
(1) Radix Et Rhizoma Rhei is made fluid extract, be heated to about 80 ℃;
(2) vegetable oil, Cera Flava and span (can not add) are mixed and heated to 80 ℃ and form liquid;
(3) with above-mentioned two liquid mixing homogenizing, be cooled to 35-40 ℃;
(4) fine powder of adding other medicines stirs.
This medicine is the mixture of plurality of Chinese, has only when they compatibilities and uses jointly, and cooperation just can produce beyond thought new more superior effect, so the present invention is creative.
This pharmaceutical composition also has significant curative effect except that burn and scald, electric burn are had the peculiar curative effect to decubital ulcer and the infection of various skin ulcer scabies.Said composition is made generally in putty-type, and trade name is " magnificent flourish skin health ointment " or " BINGSHI wound healing ointment ".
The burn and scald of the not useful as yet above-mentioned composition treatment of domestic and foreign literature at present injures the report of diseases such as decubital ulcer.Through clinical verification, its a kind of really new drug that is better than existing various medicines.
The specific embodiment
Below in conjunction with embodiment the present invention is done and to describe in further detail:
Prescription one:
Radix Et Rhizoma Rhei 15 grams, Margarita 1 gram, dried Alumen 6 grams, Gypsum Fibrosum Preparatum 20 grams, Borneolum Syntheticum 2 grams, Cera Flava 4 grams, vegetable oil 40 grams.
Prescription two:
On prescription one basis, increase Calculus Bovis 0.05 gram, Moschus 0.005 gram and span 1 gram.
To fill a prescription two is the processing technology that example illustrates this medicine:
1, make fine drug powder: get Margarita 100 gram pulverizing porphyrizes in the prescription earlier, again with Calculus Bovis 5 grams, Moschus 0.5 gram facing-up mixing is crossed 120 mesh sieves.Borneolum Syntheticum 200 grams are ground into powder with dried Alumen 600 grams, cross 120 mesh sieves behind the porphyrize, and Gypsum Fibrosum Preparatum 2000 grams are pulverized the back and crossed 120 mesh sieves, and above-mentioned each fine powder is pressed the abundant mix homogeneously of facing-up method, and are standby.
2, extract extractum rhei: get Radix Et Rhizoma Rhei 1500 grams and pulverized 120 mesh sieves,, measured 2 hours for 6 times for the first time with the reflow of alcohol lixiviate of 80% concentration 3 times, 4 times of amounts of second and third time difference, the time was respectively 1.5 and 1 hours.Merging filtrate reclaims ethanol through decompress filter, makes it to be condensed into fluid extract, and it is standby to be called second liquid.
3, make substrate: get Oleum sesami 4000 grams, Cera Flava 400 grams and span (40) 100 grams are heated to about 80 ℃ jointly, form thick liquid, claim first liquid.
4, mix: with Oleum sesami, the first liquid of Cera Flava and span composition joins in the above-mentioned Extractum Rhei Liquidum second liquid under insulated and stirred, and it is complete that the quick stirring of continuation makes it emulsifying, adds the said medicine powder when being cooled to 35～40C, does the homogenizing processing at last and gets final product.
The method that adopts prescription one to make is basic identical with prescription two, just reduces several compositions.
On the basis of this medicine claim, also may add the other medicines composition,, all belong to the protection domain of this patent as Borax, Calamina, argentum powder, Hydrargyri Oxydum Rubrum etc.
In, the Western medicine method of making ointment also has a lot, all may be used for this medicine and make.The protection domain that all belongs to this patent of all this medicament composing prescriptions of employing.
When using this medicine, wound surface is with 1% bromo geramine or other pharmacy disinfection, and cleans with normal saline.Then China's flourish skin health ointment evenly is applied to the affected part, the about 1～2mm of thickness takes exposure method.Once-a-day in early days, the next day of the later stage once.Gauze coating wrapping after the also available sterilization covers.
The Fourth Military Medical University's Xijing hospital burn department and The People's Hospital's Burn and Plastic Surgery Dept. have all carried out clinical verification to this medicine, and be remarkably productive.Detailed report is arranged, limit by length, can not give unnecessary details one by one.As examine and to enclose at any time.
This medicine is compared with existing various similar medicines, has better sterilization, putrefaction-removing granulation-promoting, detoxifcation convergence and anti-inflammatory analgetic effect.Its eutherapeutic reason may be to have improved local microcirculation, has promoted epithelial cell activation and increment, thereby has quickened wound healing.To be expected to become present treatment burn wound, one of medicine that particularly dark II burn wound is ideal.
Clinical data
Xijing hospital of The Fourth Military Medical University from May, 1998 to August, with dark II burn patient 34 examples of magnificent flourish skin health Ointment in Treatment, maximum wound surface 30 * 18cm
2, minimum is 5 * 4.5cm
2, the self-controlled group wound surface is with traditional vaseline oil yarn.Other is all treated routinely and carries out in the treatment whole process.Conclusion is: magnificent flourish skin health can be accelerated the epithelium migration velocity, promotes wound healing; Stronger anti-infection ability is arranged; Substantially not bitterly, the method for changing dressings is simple when changing dressings; Medicine raw material wide material sources, reasonable price; Safety is good, has no side effect.
The People's Hospital's Burn and Plastic Surgery Dept. is selected clinical wound surface case totally 28 examples, patients with bedsore 5 examples wherein, 7 of bedsore wounds, 3 of II degree, 4 of III degree; Area 2-3 * 4-10cm; Concurrent infection in various degree.Fire victim's 16 examples, 21 of burn woundes; Liquefied petroleum gas 9 examples of burning wherein, boiled water is scalded 6 examples, flame burn 2 examples, petrol burn 2 examples, prepared food oil and each 1 example of vapours burn; Burn surface area 4%-85%, dark II degree area 17+19.91%.Matched group burn wound adopts the husky and silver-colored gauze external application wrapping in the close shallow lake of 1% sulfanilamide of vaseline oil, and part exposes treatment for being coated with outward.There is 1 routine wound surface to contrast with upright credible gel (Italian Sha's weights is produced).The result shows that healing time all has obviously in advance than matched group, and effective percentage 100% particularly adopts the sudden and violent treatment of leaking.
Another distinguishing feature of this medicine is, not only can control burn, can also control decubital ulcer etc., helps the reparation of multiple wound surface.The early stage wound surface of this group 21 example burn are used after the magnificent flourish Ointment in Treatment and to be begun pain relieving in about 30 minutes; Shallow II degree wound healing time on average shifts to an earlier date 3-5 days than matched group.Dark II degree wound healing time shifts to an earlier date 5-6 days than matched group.Exposure treatment at the flourish ointment of treatment China of shallow II degree burn wound not only is better than phonetic shallow lakes of 1% sulfanilamide silver, founds credible gel, and obviously is better than the bandaging method for treating of Hua Rong.In the deep ii degree burn Wound treating, the exposure of magnificent flourish ointment treatment also obviously is better than the exposure treatment of all bandaging method for treating and silver sulfadiazine.And not skin-grafting of the healing of all deep ii degree burn wound surface, do not see cicatrix after the healing.
Untoward reaction takes place in none example so far in the process of using magnificent flourish Ointment in Treatment burn and bedsore wound.
Claims (4)
1, a kind ofly treat the medicine that burn and scald injures decubital ulcer, it is characterized in that mainly forming (weight portion) by following composition:
(1) Radix Et Rhizoma Rhei 10-20 part
(2) Margarita 0.1-2 part
(3) dried Alumen 2-10 part
(4) Gypsum Fibrosum Preparatum 10-35 part
(5) Borneolum Syntheticum 1-3 part
(6) Cera Flava 3-5 part
(7) vegetable oil 30-50 part
2, medicine as claimed in claim 1 is characterized in that also comprising following composition (weight portion):
Calculus Bovis 0.01-0.1 part
Moschus 0.001-0.01 part
Span 0.5-2 part
3, the method for preparing the described medicine of claim 1 is characterized in that comprising the steps:
(1) Radix Et Rhizoma Rhei is made fluid extract, be heated to about 80 ℃;
(2) vegetable oil, Cera Flava Hybrid Heating are formed liquid for 80 ℃;
(3) with two liquid mixing homogenizing, be cooled to 35-40 ℃;
(4) fine powder of adding other medicines stirs.
4, the method for preparing the described medicine of claim 2 is characterized in that comprising the steps:
(1) Radix Et Rhizoma Rhei is made fluid extract, be heated to about 80 ℃;
(2) vegetable oil, Cera Flava and span Hybrid Heating are formed liquid for 80 ℃;
(3) with two liquid mixing homogenizing, be cooled to 35-40 ℃;
(4) fine powder of adding other medicines stirs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101058270A CN1261117C (en) | 2003-10-14 | 2003-10-14 | Medicine for treating bum, empyrosis and bedsore |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101058270A CN1261117C (en) | 2003-10-14 | 2003-10-14 | Medicine for treating bum, empyrosis and bedsore |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1528413A true CN1528413A (en) | 2004-09-15 |
| CN1261117C CN1261117C (en) | 2006-06-28 |
Family
ID=34304351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101058270A Expired - Lifetime CN1261117C (en) | 2003-10-14 | 2003-10-14 | Medicine for treating bum, empyrosis and bedsore |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1261117C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104490932A (en) * | 2014-12-29 | 2015-04-08 | 高玉萍 | Externally-used medicine for recovering burned cortical tissue and preparation method thereof |
| CN104739870A (en) * | 2015-04-15 | 2015-07-01 | 刘国良 | Ointment for treating burns and scalds |
| CN105148147A (en) * | 2015-10-21 | 2015-12-16 | 覃佳林 | Traditional Chinese medicine for treating wound or bedsore infection and preparation method thereof |
| CN105381101A (en) * | 2015-12-03 | 2016-03-09 | 张东 | Medicine used for treating burns, scalds and bedsore and preparation method thereof |
| CN108186712A (en) * | 2018-03-16 | 2018-06-22 | 唐天左 | The production method of SHENGJI BAIYU GAO |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102416089B (en) * | 2011-11-18 | 2013-08-28 | 韩传瑞 | Externally applied Chinese herbal ointment and preparation method thereof |
-
2003
- 2003-10-14 CN CNB2003101058270A patent/CN1261117C/en not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104490932A (en) * | 2014-12-29 | 2015-04-08 | 高玉萍 | Externally-used medicine for recovering burned cortical tissue and preparation method thereof |
| CN104490932B (en) * | 2014-12-29 | 2018-03-06 | 高玉萍 | It is a kind of to bring back to life external used medicine for scalding burn cortical tissue and preparation method thereof |
| CN104739870A (en) * | 2015-04-15 | 2015-07-01 | 刘国良 | Ointment for treating burns and scalds |
| CN105148147A (en) * | 2015-10-21 | 2015-12-16 | 覃佳林 | Traditional Chinese medicine for treating wound or bedsore infection and preparation method thereof |
| CN105381101A (en) * | 2015-12-03 | 2016-03-09 | 张东 | Medicine used for treating burns, scalds and bedsore and preparation method thereof |
| CN108186712A (en) * | 2018-03-16 | 2018-06-22 | 唐天左 | The production method of SHENGJI BAIYU GAO |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1261117C (en) | 2006-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1261117C (en) | Medicine for treating bum, empyrosis and bedsore | |
| WO2012100754A1 (en) | Chinese medicine composition for treating stab wounds, burns, and various traumas | |
| CN1183950C (en) | Chinese herbal medicine preparation for treating burns | |
| CN1079257C (en) | Powder medicine for treating born and scald | |
| CN1259098C (en) | Exterior-applied Chinese herbal medicine preparation for traumatic infection and inflammation-relieving acesodyne and its preparation method | |
| CN1068785C (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
| CN101342316B (en) | Traditional Chinese medicine externally used combined formulation for treating burn | |
| CN1476868A (en) | Ointment for external application for curing scald and burn | |
| CN1939470A (en) | Chinese medicinal plaster with analgetic, hemostatic repercussive and sore-arresting functions | |
| CN1067902C (en) | Decrustation ointment for burn and its preparing process | |
| CN1258367C (en) | Medicine for treating trauma | |
| CN1439413A (en) | Chinese medicine against skin and external diseases | |
| CN1839898A (en) | Scar-free wet ointment for scald and burn and its preparation method | |
| CN1239180C (en) | Medicine for treating piles | |
| CN1050298C (en) | Traditional Chinese medicine powder for bone-setting, and method for preparing same | |
| CN1059585C (en) | A new type scald ointment | |
| CN1391950A (en) | Acne clearing liquid | |
| CN1850224A (en) | Medicine for treating scald and burn and preparing method | |
| CN101259200A (en) | Orally-administered and externally-applied specific medicine for treating bone injury disease, protrusion of lumbar intervertebral discs and wrick | |
| CN1082427A (en) | Universal incised wound oil and preparation method thereof | |
| CN1160082C (en) | Medicine for curing burn and scald | |
| CN1061888C (en) | Medicine for treating intractable ulcer and its preparing process | |
| CN1095921A (en) | Ointment for burns and scalds and manufacture method thereof | |
| CN100496460C (en) | Externally applied agent for treating purulent diseases | |
| CN116531460A (en) | Traditional Chinese medicine powder for treating huge bedsores and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20060628 |
|
| CX01 | Expiry of patent term |